Phillips Medisize

Phillips Medisize employee working in the pharmaceutical technology service lab, while we can see another employee walk past outside the window. Through the window, another corridor shows another employee in a neighbouring room.

INHALATION AND NASAL EXPERTISE

The 2025 Vectura acquisition expanded our capabilities. Today, we specialize in innovative inhaled drug development, leveraging more than 25 years of experience to help bring your medicines to market. Our combination of formulation science, device technology and inhaled development expertise has contributed to the success of 13 inhaled medicines launched by our partners and licensees. In 2020 alone, these products were used by 10 million patients worldwide.1

Our expertise spans small molecules, biologics, complex combinations and generic products for pMDI, DPI, nasal inhaler and nebulization devices. We invite you to explore more about our proven inhalation services:

A Phillips Medisize employee working in a pharmaceutical clean room, wearing a lab coat, gloves and protective glasses, he is working on developing inhalation products
Inhalation Product Development
Learn More
A close-up image of a Phillips Medisize scientist, working on formulation for an inhalation device. The scientist holds a glass bottle wearing gloves.
Inhalation Formulation Expertise
Learn More
An image of the FOX Vibrating Mesh Nebulizer being tested as part of the pharmaceutical analysis process
Inhalation Pharmaceutical Analysis
Learn More
A close up image of a roll of blister packaging feeding through a machine to be prepared to be inserted into a dry powder inhaler
Bespoke Inhalation Device Design
Learn More
An image of a scientist in a lab coat and wearing PPE while working on machinery to develop and produce inhalation products
Inhalation Clinical Trial Production and Supply
Learn More

Our Track Record

Fluticasone Proprionate & SalmeterolHikma
Formulation + Device + Development
flutiform™ 2
Mundipharma, Kyorin
Mundipharma, Kyorin
flutiform™ k-haler™ 2
Mundipharma, Kyorin
Formulation + Device + Development
Airbufo™ Forspiro™ 3
Sandoz
Formulation + Device + Development
AirFluSal™ Forspiro™ 3
Sandoz
Formulation + Device + Development
Breelib™4Bayer
Formulation + Device + Development
Seebri™ Breezhaler™ 3
Novartis
Formulation
Ultibro™ Breezhaler™ 3
Novartis
Formulation
Enerzair™ Breezhaler™ 3
Novartis
Formulation
Relvar™ Ellipta™ 5
GSK
Formulation
Anoro™ Ellipta™ 5
GSK
Formulation
Incruse™ Ellipta™ 5
GSK
Formulation
Trelegy™ Ellipta™ 5
GSK
Formulation

1. Evaluate Pharma; internal estimates 2. flutiform™ is a registered trademark of Jagotec AG, a Vectura company. K-haler™ is a registered trademark of Mundipharma AG. 3. AirFluSal™, Airbufo® and Forspiro™ are registered trademarks of Novartis AG 4. Breelib™ is a registered trademark of Bayer Intellectual Property GmbH 5. Registered trademarks of Glaxo Group Ltd. Formulation technology license, product not developed by Vectura.

Featured Resources

Fact Sheet
Phillips Medisize – Supporting Your Journey to Market
You have ideas for empowering patients and improving lives. We can help. Download.
Literature
Phillips Medisize corporate brochure
We are trusted by leading pharmaceutical, medtech, and in vitro diagnostic companies worldwide to design and manufacture their products. Download.
Webpage
Phillips Medisize building against blue sky
Discover our global footprint
Learn more about our production facilities, our experienced engineering and manufacturing teams, and our state-of-the-art manufacturing equipment. Discover more.

Connect With One of Our Team Members to Begin Your Journey Today.

CONTACT US